Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Use of dietary supplements containing soy isoflavones and breast cancer risk among women aged >50 y: a prospective study.

Touillaud M, Gelot A, Mesrine S, Bennetau-Pelissero C, Clavel-Chapelon F, Arveux P, Bonnet F, Gunter M, Boutron-Ruault MC, Fournier A.

Am J Clin Nutr. 2019 Mar 1;109(3):597-605. doi: 10.1093/ajcn/nqy313.

PMID:
30831601
2.

Risk of asthma onset after natural and surgical menopause: Results from the French E3N cohort.

Matulonga-Diakiese B, Courbon D, Fournier A, Sanchez M, Bédard A, Mesrine S, Taillé C, Severi G, Thabut G, Varraso R, Leynaert B.

Maturitas. 2018 Dec;118:44-50. doi: 10.1016/j.maturitas.2018.10.006. Epub 2018 Oct 24.

PMID:
30415754
3.

[Additional non-contraceptive effects of contraception: CNGOF Contraception Guidelines].

Amat L, Bulach A, Leclercq M, Mesrine S, Scheffler F, Sperandeo D, Scheffler M.

Gynecol Obstet Fertil Senol. 2018 Dec;46(12):883-888. doi: 10.1016/j.gofs.2018.10.013. Epub 2018 Nov 7. French.

PMID:
30414725
4.

Relation between hysterectomy, oophorectomy and the risk of incident differentiated thyroid cancer: The E3N cohort.

Guenego A, Mesrine S, Dartois L, Leenhardt L, Clavel-Chapelon F, Kvaskoff M, Boutron-Ruault MC, Bonnet F.

Clin Endocrinol (Oxf). 2019 Feb;90(2):360-368. doi: 10.1111/cen.13899. Epub 2018 Dec 3.

PMID:
30390407
5.

Use of benzodiazepines and cardiovascular mortality in a cohort of women aged over 50 years.

Mesrine S, Gusto G, Clavel-Chapelon F, Boutron-Ruault MC, Fournier A.

Eur J Clin Pharmacol. 2018 Nov;74(11):1475-1484. doi: 10.1007/s00228-018-2515-4. Epub 2018 Jul 4.

PMID:
29971451
6.

Life course evolution of body size and breast cancer survival in the E3N cohort.

His M, Le Guélennec M, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F, Fagherazzi G, Dossus L.

Int J Cancer. 2018 Apr 15;142(8):1542-1553. doi: 10.1002/ijc.31177. Epub 2017 Dec 15.

7.

Endometriosis and the risk of skin cancer: a prospective cohort study.

Farland LV, Lorrain S, Missmer SA, Dartois L, Cervenka I, Savoye I, Mesrine S, Boutron-Ruault MC, Kvaskoff M.

Cancer Causes Control. 2017 Oct;28(10):1011-1019. doi: 10.1007/s10552-017-0939-2. Epub 2017 Aug 10.

8.

Use of Bisphosphonates and Risk of Breast Cancer in a French Cohort of Postmenopausal Women.

Fournier A, Mesrine S, Gelot A, Fagherazzi G, Baglietto L, Clavel-Chapelon F, Boutron-Ruault MC, Chabbert-Buffet N.

J Clin Oncol. 2017 Oct 1;35(28):3230-3239. doi: 10.1200/JCO.2016.71.4337. Epub 2017 Jul 14.

PMID:
28708471
9.

Associations among body size across the life course, adult height and endometriosis.

Farland LV, Missmer SA, Bijon A, Gusto G, Gelot A, Clavel-Chapelon F, Mesrine S, Boutron-Ruault MC, Kvaskoff M.

Hum Reprod. 2017 Aug 1;32(8):1732-1742. doi: 10.1093/humrep/dex207.

10.

Nevi, Ambient Ultraviolet Radiation, and Thyroid Cancer Risk: A French Prospective Study.

Mesrine S, Kvaskoff M, Bah T, Wald L, Clavel-Chapelon F, Boutron-Ruault MC.

Epidemiology. 2017 Sep;28(5):694-702. doi: 10.1097/EDE.0000000000000673.

PMID:
28383300
11.

Measured Adiposity in Relation to Head and Neck Cancer Risk in the European Prospective Investigation into Cancer and Nutrition.

Ward HA, Wark PA, Muller DC, Steffen A, Johansson M, Norat T, Gunter MJ, Overvad K, Dahm CC, Halkjær J, Tjønneland A, Boutron-Ruault MC, Fagherazzi G, Mesrine S, Brennan P, Freisling H, Li K, Kaaks R, Trichopoulou A, Lagiou P, Panico S, Grioni S, Tumino R, Vineis P, Palli D, Peeters PHM, Bueno-de-Mesquita HB, Weiderpass E, Agudo A, Quirós JR, Larrañaga N, Ardanaz E, Huerta JM, Sánchez MJ, Laurell G, Johansson I, Westin U, Wallström P, Bradbury KE, Wareham NJ, Khaw KT, Pearson C, Boeing H, Riboli E.

Cancer Epidemiol Biomarkers Prev. 2017 Jun;26(6):895-904. doi: 10.1158/1055-9965.EPI-16-0886. Epub 2017 Feb 9.

12.

Associations between serum lipids and breast cancer incidence and survival in the E3N prospective cohort study.

His M, Dartois L, Fagherazzi G, Boutten A, Dupré T, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F, Dossus L.

Cancer Causes Control. 2017 Jan;28(1):77-88. doi: 10.1007/s10552-016-0832-4. Epub 2016 Nov 18.

PMID:
27864712
13.

Postmenopausal breast cancer risk and interactions between body mass index, menopausal hormone therapy use, and vitamin D supplementation: Evidence from the E3N cohort.

Cadeau C, Fournier A, Mesrine S, Clavel-Chapelon F, Fagherazzi G, Boutron-Ruault MC.

Int J Cancer. 2016 Nov 15;139(10):2193-200. doi: 10.1002/ijc.30282. Epub 2016 Jul 30.

14.

Vitamin C supplement intake and postmenopausal breast cancer risk: interaction with dietary vitamin C.

Cadeau C, Fournier A, Mesrine S, Clavel-Chapelon F, Fagherazzi G, Boutron-Ruault MC.

Am J Clin Nutr. 2016 Jul;104(1):228-34. doi: 10.3945/ajcn.115.126326. Epub 2016 May 18.

PMID:
27194303
15.

Prediagnostic body size and breast cancer survival in the E3N cohort study.

His M, Fagherazzi G, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F, Dossus L.

Int J Cancer. 2016 Sep 1;139(5):1053-64. doi: 10.1002/ijc.30158. Epub 2016 May 14.

16.

A Prospective Evaluation of Early Detection Biomarkers for Ovarian Cancer in the European EPIC Cohort.

Terry KL, Schock H, Fortner RT, Hüsing A, Fichorova RN, Yamamoto HS, Vitonis AF, Johnson T, Overvad K, Tjønneland A, Boutron-Ruault MC, Mesrine S, Severi G, Dossus L, Rinaldi S, Boeing H, Benetou V, Lagiou P, Trichopoulou A, Krogh V, Kuhn E, Panico S, Bueno-de-Mesquita HB, Onland-Moret NC, Peeters PH, Gram IT, Weiderpass E, Duell EJ, Sanchez MJ, Ardanaz E, Etxezarreta N, Navarro C, Idahl A, Lundin E, Jirström K, Manjer J, Wareham NJ, Khaw KT, Byrne KS, Travis RC, Gunter MJ, Merritt MA, Riboli E, Cramer DW, Kaaks R.

Clin Cancer Res. 2016 Sep 15;22(18):4664-75. doi: 10.1158/1078-0432.CCR-16-0316. Epub 2016 Apr 8.

17.

Correction: The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort.

Roura E, Travier N, Waterboer T, de Sanjosé S, Bosch FX, Pawlita M, Pala V, Weiderpass E, Margall N, Dillner J, Gram IT, Tjønneland A, Munk C, Palli D, Khaw KT, Overvad K, Clavel-Chapelon F, Mesrine S, Fournier A, Fortner RT, Ose J, Steffen A, Trichopoulou A, Lagiou P, Orfanos P, Masala G, Tumino R, Sacerdote C, Polidoro S, Mattiello A, Lund E, Peeters PH, Bueno-de-Mesquita HB, Ramón Quirós J, Sánchez MJ, Navarro C, Barricarte A, Larrañaga N, Ekström J, Lindquist D, Idahl A, Travis RC, Merritt MA, Gunter MJ, Rinaldi S, Tommasino M, Franceschi S, Riboli E, Castellsagué X.

PLoS One. 2016 Mar 8;11(3):e0151427. doi: 10.1371/journal.pone.0151427. eCollection 2016. No abstract available.

18.

The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort.

Roura E, Travier N, Waterboer T, de Sanjosé S, Bosch FX, Pawlita M, Pala V, Weiderpass E, Margall N, Dillner J, Gram IT, Tjønneland A, Munk C, Palli D, Khaw KT, Overvad K, Clavel-Chapelon F, Mesrine S, Fournier A, Fortner RT, Ose J, Steffen A, Trichopoulou A, Lagiou P, Orfanos P, Masala G, Tumino R, Sacerdote C, Polidoro S, Mattiello A, Lund E, Peeters PH, Bueno-de-Mesquita HB, Quirós JR, Sánchez MJ, Navarro C, Barricarte A, Larrañaga N, Ekström J, Lindquist D, Idahl A, Travis RC, Merritt MA, Gunter MJ, Rinaldi S, Tommasino M, Franceschi S, Riboli E, Castellsagué X.

PLoS One. 2016 Jan 25;11(1):e0147029. doi: 10.1371/journal.pone.0147029. eCollection 2016. Erratum in: PLoS One. 2016;11(3):e0151427.

19.

Proportion of premenopausal and postmenopausal breast cancers attributable to known risk factors: Estimates from the E3N-EPIC cohort.

Dartois L, Fagherazzi G, Baglietto L, Boutron-Ruault MC, Delaloge S, Mesrine S, Clavel-Chapelon F.

Int J Cancer. 2016 May 15;138(10):2415-27. doi: 10.1002/ijc.29987. Epub 2016 Feb 4.

20.

Reproductive factors and epithelial ovarian cancer survival in the EPIC cohort study.

Bešević J, Gunter MJ, Fortner RT, Tsilidis KK, Weiderpass E, Onland-Moret NC, Dossus L, Tjønneland A, Hansen L, Overvad K, Mesrine S, Baglietto L, Clavel-Chapelon F, Kaaks R, Aleksandrova K, Boeing H, Trichopoulou A, Lagiou P, Bamia C, Masala G, Agnoli C, Tumino R, Ricceri F, Panico S, Bueno-de-Mesquita HB, Peeters PH, Jareid M, Quirós JR, Duell EJ, Sánchez MJ, Larrañaga N, Chirlaque MD, Barricarte A, Dias JA, Sonestedt E, Idahl A, Lundin E, Wareham NJ, Khaw KT, Travis RC, Rinaldi S, Romieu I, Riboli E, Merritt MA.

Br J Cancer. 2015 Dec 1;113(11):1622-31. doi: 10.1038/bjc.2015.377. Epub 2015 Nov 10.

21.

Acrylamide and glycidamide hemoglobin adduct levels and endometrial cancer risk: A nested case-control study in nonsmoking postmenopausal women from the EPIC cohort.

Obón-Santacana M, Freisling H, Peeters PH, Lujan-Barroso L, Ferrari P, Boutron-Ruault MC, Mesrine S, Baglietto L, Turzanski-Fortner R, Katzke VA, Boeing H, Quirós JR, Molina-Portillo E, Larrañaga N, Chirlaque MD, Barricarte A, Khaw KT, Wareham N, Travis RC, Merritt MA, Gunter MJ, Trichopoulou A, Lagiou P, Naska A, Palli D, Sieri S, Tumino R, Fiano V, Galassom R, Bueno-de-Mesquita HB, Onland-Moret NC, Idahl A, Lundin E, Weiderpass E, Vesper H, Riboli E, Duell EJ.

Int J Cancer. 2016 Mar 1;138(5):1129-38. doi: 10.1002/ijc.29853. Epub 2015 Oct 1.

22.

Interaction between current vitamin D supplementation and menopausal hormone therapy use on breast cancer risk: evidence from the E3N cohort.

Cadeau C, Fournier A, Mesrine S, Clavel-Chapelon F, Fagherazzi G, Boutron-Ruault MC.

Am J Clin Nutr. 2015 Oct;102(4):966-73. doi: 10.3945/ajcn.114.104323. Epub 2015 Sep 9.

PMID:
26354532
23.

Energy and macronutrient intake and risk of differentiated thyroid carcinoma in the European Prospective Investigation into Cancer and Nutrition study.

Zamora-Ros R, Rinaldi S, Tsilidis KK, Weiderpass E, Boutron-Ruault MC, Rostgaard-Hansen AL, Tjønneland A, Clavel-Chapelon F, Mesrine S, Katzke VA, Kühn T, Förster J, Boeing H, Trichopoulou A, Lagiou P, Klinaki E, Masala G, Sieri S, Ricceri F, Tumino R, Mattiello A, Peeters PH, Bueno-de-Mesquita HB, Engeset D, Skeie G, Argüelles M, Agudo A, Sánchez MJ, Chirlaque MD, Barricarte A, Chamosa S, Almquist M, Tosovic A, Hennings J, Sandström M, Schmidt JA, Khaw KT, Wareham NJ, Cross AJ, Slimani N, Byrnes G, Romieu I, Riboli E, Franceschi S.

Int J Cancer. 2016 Jan 1;138(1):65-73. doi: 10.1002/ijc.29693. Epub 2015 Jul 30.

24.

A comparison between different prediction models for invasive breast cancer occurrence in the French E3N cohort.

Dartois L, Gauthier É, Heitzmann J, Baglietto L, Michiels S, Mesrine S, Boutron-Ruault MC, Delaloge S, Ragusa S, Clavel-Chapelon F, Fagherazzi G.

Breast Cancer Res Treat. 2015 Apr;150(2):415-26. doi: 10.1007/s10549-015-3321-7. Epub 2015 Mar 6.

PMID:
25744293
25.

Physical activity and all-cause mortality across levels of overall and abdominal adiposity in European men and women: the European Prospective Investigation into Cancer and Nutrition Study (EPIC).

Ekelund U, Ward HA, Norat T, Luan J, May AM, Weiderpass E, Sharp SJ, Overvad K, Østergaard JN, Tjønneland A, Johnsen NF, Mesrine S, Fournier A, Fagherazzi G, Trichopoulou A, Lagiou P, Trichopoulos D, Li K, Kaaks R, Ferrari P, Licaj I, Jenab M, Bergmann M, Boeing H, Palli D, Sieri S, Panico S, Tumino R, Vineis P, Peeters PH, Monnikhof E, Bueno-de-Mesquita HB, Quirós JR, Agudo A, Sánchez MJ, Huerta JM, Ardanaz E, Arriola L, Hedblad B, Wirfält E, Sund M, Johansson M, Key TJ, Travis RC, Khaw KT, Brage S, Wareham NJ, Riboli E.

Am J Clin Nutr. 2015 Mar;101(3):613-21. doi: 10.3945/ajcn.114.100065. Epub 2015 Jan 14.

26.

Human papillomavirus antibodies and future risk of anogenital cancer: a nested case-control study in the European prospective investigation into cancer and nutrition study.

Kreimer AR, Brennan P, Lang Kuhs KA, Waterboer T, Clifford G, Franceschi S, Michel A, Willhauck-Fleckenstein M, Riboli E, Castellsagué X, Hildesheim A, Fortner RT, Kaaks R, Palli D, Ljuslinder I, Panico S, Clavel-Chapelon F, Boutron-Ruault MC, Mesrine S, Trichopoulou A, Lagiou P, Trichopoulos D, Peeters PH, Cross AJ, Bueno-de-Mesquita HB, Vineis P, Larrañaga N, Pala V, Sánchez MJ, Navarro C, Barricarte A, Tumino R, Khaw KT, Wareham N, Boeing H, Steffen A, Travis RC, Quirós JR, Weiderpass E, Pawlita M, Johansson M.

J Clin Oncol. 2015 Mar 10;33(8):877-84. doi: 10.1200/JCO.2014.57.8435. Epub 2015 Feb 9.

27.

Recent recreational physical activity and breast cancer risk in postmenopausal women in the E3N cohort.

Fournier A, Dos Santos G, Guillas G, Bertsch J, Duclos M, Boutron-Ruault MC, Clavel-Chapelon F, Mesrine S.

Cancer Epidemiol Biomarkers Prev. 2014 Sep;23(9):1893-902. doi: 10.1158/1055-9965.EPI-14-0150. Epub 2014 Aug 11.

28.

Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: the EPIC study.

Zamora-Ros R, Rinaldi S, Biessy C, Tjønneland A, Halkjaer J, Fournier A, Boutron-Ruault MC, Mesrine S, Tikk K, Fortner RT, Boeing H, Förster J, Trichopoulou A, Trichopoulos D, Papatesta EM, Masala G, Tagliabue G, Panico S, Tumino R, Polidoro S, Peeters PH, Bueno-de-Mesquita HB, Weiderpass E, Lund E, Argüelles M, Agudo A, Molina-Montes E, Navarro C, Barricarte A, Larrañaga N, Manjer J, Almquist M, Sandström M, Hennings J, Tsilidis KK, Schmidt JA, Khaw KT, Wareham NJ, Romieu I, Byrnes G, Gunter MJ, Riboli E, Franceschi S.

Int J Cancer. 2015 Mar 1;136(5):1218-27. doi: 10.1002/ijc.29067. Epub 2014 Jul 22.

29.

Risks of endometrial cancer associated with different hormone replacement therapies in the E3N cohort, 1992-2008.

Fournier A, Dossus L, Mesrine S, Vilier A, Boutron-Ruault MC, Clavel-Chapelon F, Chabbert-Buffet N.

Am J Epidemiol. 2014 Sep 1;180(5):508-17. doi: 10.1093/aje/kwu146. Epub 2014 Jul 9.

PMID:
25008104
30.

Anthropometric features and cutaneous melanoma risk: a prospective cohort study in French women.

Kvaskoff M, Bijon A, Mesrine S, Vilier A, Clavel-Chapelon F, Boutron-Ruault MC.

Cancer Epidemiol. 2014 Aug;38(4):357-63. doi: 10.1016/j.canep.2014.05.008. Epub 2014 Jun 28.

PMID:
24986641
31.

Association between melanocytic nevi and risk of breast diseases: The French E3N prospective cohort.

Kvaskoff M, Bijon A, Mesrine S, Vilier A, Baglietto L, Fournier A, Clavel-Chapelon F, Dossus L, Boutron-Ruault MC.

PLoS Med. 2014 Jun 10;11(6):e1001660. doi: 10.1371/journal.pmed.1001660. eCollection 2014 Jun.

32.

Body-size throughout life and risk of depression in postmenopausal women: findings from the E3N cohort.

Perquier F, Lasfargues A, Mesrine S, Clavel-Chapelon F, Fagherazzi G.

Obesity (Silver Spring). 2014 Aug;22(8):1926-34. doi: 10.1002/oby.20799. Epub 2014 Jun 4.

33.

Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort.

Fournier A, Mesrine S, Dossus L, Boutron-Ruault MC, Clavel-Chapelon F, Chabbert-Buffet N.

Breast Cancer Res Treat. 2014 Jun;145(2):535-43. doi: 10.1007/s10549-014-2934-6. Epub 2014 Apr 30. Erratum in: Breast Cancer Res Treat. 2014 Aug;147(1):225.

34.

Weight change in middle adulthood and breast cancer risk in the EPIC-PANACEA study.

Emaus MJ, van Gils CH, Bakker MF, Bisschop CN, Monninkhof EM, Bueno-de-Mesquita HB, Travier N, Berentzen TL, Overvad K, Tjønneland A, Romieu I, Rinaldi S, Chajes V, Gunter MJ, Clavel-Chapelon F, Fagherazzi G, Mesrine S, Chang-Claude J, Kaaks R, Boeing H, Aleksandrova K, Trichopoulou A, Naska A, Orfanos P, Palli D, Agnoli C, Tumino R, Vineis P, Mattiello A, Braaten T, Borch KB, Lund E, Menéndez V, Sánchez MJ, Navarro C, Barricarte A, Amiano P, Sund M, Andersson A, Borgquist S, Olsson A, Khaw KT, Wareham N, Travis RC, Riboli E, Peeters PH, May AM.

Int J Cancer. 2014 Dec 15;135(12):2887-99. doi: 10.1002/ijc.28926. Epub 2014 May 16.

35.

Alcohol consumption and breast cancer risk subtypes in the E3N-EPIC cohort.

Fagherazzi G, Vilier A, Boutron-Ruault MC, Mesrine S, Clavel-Chapelon F.

Eur J Cancer Prev. 2015 May;24(3):209-14. doi: 10.1097/CEJ.0000000000000031.

PMID:
24743350
36.

Insulin-like growth factor-i and risk of differentiated thyroid carcinoma in the European prospective investigation into cancer and nutrition.

Schmidt JA, Allen NE, Almquist M, Franceschi S, Rinaldi S, Tipper SJ, Tsilidis KK, Weiderpass E, Overvad K, Tjønneland A, Boutron-Ruault MC, Dossus L, Mesrine S, Kaaks R, Lukanova A, Boeing H, Lagiou P, Trichopoulos D, Trichopoulou A, Palli D, Krogh V, Panico S, Tumino R, Zanetti R, Bueno-de-Mesquita HB, Peeters PH, Lund E, Menéndez V, Agudo A, Sánchez MJ, Chirlaque MD, Ardanaz E, Larrañaga N, Hennings J, Sandström M, Khaw KT, Wareham N, Romieu I, Gunter MJ, Riboli E, Key TJ, Travis RC.

Cancer Epidemiol Biomarkers Prev. 2014 Jun;23(6):976-85. doi: 10.1158/1055-9965.EPI-13-1210-T. Epub 2014 Mar 19.

37.

Association between five lifestyle habits and cancer risk: results from the E3N cohort.

Dartois L, Fagherazzi G, Boutron-Ruault MC, Mesrine S, Clavel-Chapelon F.

Cancer Prev Res (Phila). 2014 May;7(5):516-25. doi: 10.1158/1940-6207.CAPR-13-0325. Epub 2014 Feb 26.

38.

C-reactive protein and postmenopausal breast cancer risk: results from the E3N cohort study.

Dossus L, Jimenez-Corona A, Romieu I, Boutron-Ruault MC, Boutten A, Dupré T, Fagherazzi G, Clavel-Chapelon F, Mesrine S.

Cancer Causes Control. 2014 Apr;25(4):533-9. doi: 10.1007/s10552-014-0355-9. Epub 2014 Feb 7.

PMID:
24504436
39.

[Risk of cancer associated with nutrition and physical inactivity].

Clavel-Chapelon F, Mesrine S.

Rev Prat. 2013 Oct;63(8):1113-7. Review. French.

PMID:
24298830
40.

Physical activity, sex steroid, and growth factor concentrations in pre- and post-menopausal women: a cross-sectional study within the EPIC cohort.

Rinaldi S, Kaaks R, Friedenreich CM, Key TJ, Travis R, Biessy C, Slimani N, Overvad K, Østergaard JN, Tjønneland A, Olsen A, Mesrine S, Fournier A, Dossus L, Lukanova A, Johnson T, Boeing H, Vigl M, Trichopoulou A, Benetou V, Trichopoulos D, Masala G, Krogh V, Tumino R, Ricceri F, Panico S, Bueno-de-Mesquita HB, Monninkhof EM, May AM, Weiderpass E, Quirós JR, Travier N, Molina-Montes E, Amiano P, Huerta JM, Ardanaz E, Sund M, Johansson M, Khaw KT, Wareham N, Scalbert A, Gunter MJ, Riboli E, Romieu I.

Cancer Causes Control. 2014 Jan;25(1):111-24. doi: 10.1007/s10552-013-0314-x. Epub 2013 Oct 31.

PMID:
24173534
41.

Lifetime endogenous reproductive factors and severe depressive symptoms in postmenopausal women: findings from the E3N cohort.

Perquier F, Ryan J, Ancelin ML, Mesrine S, Clavel-Chapelon F.

Menopause. 2013 Nov;20(11):1154-63. doi: 10.1097/GME.0000000000000098.

PMID:
24149927
42.

Re: "Dairy-food, calcium, magnesium, and vitamin D intake and endometriosis: a prospective cohort study".

Mesrine S, Clavel-Chapelon F, Boutron-Ruault MC.

Am J Epidemiol. 2013 Aug 15;178(4):664-5. doi: 10.1093/aje/kwt150. Epub 2013 Jul 23. No abstract available.

PMID:
23880352
43.

Functional outcomes after treatment for prostate cancer.

Mesrine S, Clavel-Chapelon F, Boutron-Ruault MC.

N Engl J Med. 2013 Apr 25;368(17):1653-4. doi: 10.1056/NEJMc1302509. No abstract available.

PMID:
23614597
44.

Latitude and ultraviolet radiation dose in the birthplace in relation to menarcheal age in a large cohort of French women.

Dossus L, Kvaskoff M, Bijon A, Engel P, Verdebout J, Fervers B, Boutron-Ruault MC, Clavel-Chapelon F, Mesrine S.

Int J Epidemiol. 2013 Apr;42(2):590-600. doi: 10.1093/ije/dyt007.

45.

Menopausal hormone therapy and risk of cholecystectomy: a prospective study based on the French E3N cohort.

Racine A, Bijon A, Fournier A, Mesrine S, Clavel-Chapelon F, Carbonnel F, Boutron-Ruault MC.

CMAJ. 2013 Apr 16;185(7):555-61. doi: 10.1503/cmaj.121490. Epub 2013 Mar 18.

46.

Hormonal, metabolic, and inflammatory profiles and endometrial cancer risk within the EPIC cohort--a factor analysis.

Dossus L, Lukanova A, Rinaldi S, Allen N, Cust AE, Becker S, Tjonneland A, Hansen L, Overvad K, Chabbert-Buffet N, Mesrine S, Clavel-Chapelon F, Teucher B, Chang-Claude J, Boeing H, Drogan D, Trichopoulou A, Benetou V, Bamia C, Palli D, Agnoli C, Galasso R, Tumino R, Sacerdote C, Bueno-de-Mesquita HB, van Duijnhoven FJ, Peeters PH, Onland-Moret NC, Redondo ML, Travier N, Sanchez MJ, Altzibar JM, Chirlaque MD, Barricarte A, Lundin E, Khaw KT, Wareham N, Fedirko V, Romieu I, Romaguera D, Norat T, Riboli E, Kaaks R.

Am J Epidemiol. 2013 Apr 15;177(8):787-99. doi: 10.1093/aje/kws309. Epub 2013 Mar 13.

PMID:
23492765
47.

Childhood and adolescent exposures and the risk of endometriosis.

Kvaskoff M, Bijon A, Clavel-Chapelon F, Mesrine S, Boutron-Ruault MC.

Epidemiology. 2013 Mar;24(2):261-9. doi: 10.1097/EDE.0b013e3182806445.

PMID:
23337239
48.

Height, age at menarche and risk of hormone receptor-positive and -negative breast cancer: a cohort study.

Ritte R, Lukanova A, Tjønneland A, Olsen A, Overvad K, Mesrine S, Fagherazzi G, Dossus L, Teucher B, Steindorf K, Boeing H, Aleksandrova K, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Grioni S, Mattiello A, Tumino R, Sacerdote C, Quirós JR, Buckland G, Molina-Montes E, Chirlaque MD, Ardanaz E, Amiano P, Bueno-de-Mesquita B, van Duijnhoven F, van Gils CH, Peeters PH, Wareham N, Khaw KT, Key TJ, Travis RC, Krum-Hansen S, Gram IT, Lund E, Sund M, Andersson A, Romieu I, Rinaldi S, McCormack V, Riboli E, Kaaks R.

Int J Cancer. 2013 Jun 1;132(11):2619-29. doi: 10.1002/ijc.27913. Epub 2012 Nov 14.

49.

Determinants of age at menarche and time to menstrual cycle regularity in the French E3N cohort.

Dossus L, Kvaskoff M, Bijon A, Fervers B, Boutron-Ruault MC, Mesrine S, Clavel-Chapelon F.

Ann Epidemiol. 2012 Oct;22(10):723-30. doi: 10.1016/j.annepidem.2012.07.007. Epub 2012 Aug 14.

PMID:
22902044
50.

Body shape throughout life and the risk for breast cancer at adulthood in the French E3N cohort.

Fagherazzi G, Guillas G, Boutron-Ruault MC, Clavel-Chapelon F, Mesrine S.

Eur J Cancer Prev. 2013 Jan;22(1):29-37. doi: 10.1097/CEJ.0b013e328355ec04.

PMID:
22694827

Supplemental Content

Loading ...
Support Center